CD200 and B-cell chronic lymphocytic leukemia: Finally, there is some evidence that serum levels of soluble CD200 may be related to disease progression and prognosis in patients with CLL (79, 81, 82). In particular, Wong et al showed that CD200 can be released from CD200+ neoplastic cells by ectodomain shedding (81).